Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

252 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Incidence of side effects during therapy with different types of alpha interferon: a randomised controlled trial comparing recombinant alpha 2b versus leukocyte interferon in the therapy of naive patients with chronic hepatitis C.
Ascione A, De Luca M, Di Costanzo GG, Picciotto FP, Lanza AG, Canestrini C, Morisco F, Tuccillo C, Caporaso N. Ascione A, et al. Among authors: morisco f. Curr Pharm Des. 2002;8(11):977-80. doi: 10.2174/1381612024607018. Curr Pharm Des. 2002. PMID: 11945144 Clinical Trial.
The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism.
Carella C, Mazziotti G, Morisco F, Rotondi M, Cioffi M, Tuccillo C, Sorvillo F, Caporaso N, Amato G. Carella C, et al. Among authors: morisco f. Eur J Endocrinol. 2002 Jun;146(6):743-9. doi: 10.1530/eje.0.1460743. Eur J Endocrinol. 2002. PMID: 12039693
Retrospective, observational, multicentre study on an Italian population affected by chronic hepatitis C who failed to clear HCV-RNA after the combined therapy (PEG-IFN and ribavirin): NADIR study.
Morisco F, Stroffolini T, Medda E, Amoruso DC, Almasio PL, Villa E, Zuin M, Paris B, Stanzione M, Caporaso N; NADIR Study Group. Morisco F, et al. J Viral Hepat. 2010 Jun;17(6):427-34. doi: 10.1111/j.1365-2893.2009.01200.x. Epub 2009 Sep 25. J Viral Hepat. 2010. PMID: 19780939
252 results